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Abstract 
The Apolipoprotein E4 (ApoE-ε4) allele has been suggested as the main risk factor for 
late onset Alzheimer’s disease (AD), whereas the ApoE-ε2 allele has been proposed as a 
protective factor. These proposals have increased the interest in the effect of the ApoE 
genotype in healthy people. Additionally, high cortisol levels have been related to 
negative effects on cognition. However, few studies have investigated the relationship 
between cognitive performance and cortisol, taking into account the different ApoE 
alleles. For this reason, the aim of this study was to evaluate different cognitive domains 
(declarative and working memory, attention, and executive function) and their 
relationship with cortisol, considering the ApoE-ε2, ApoE-ε3, and ApoE-ε4 alleles in 
healthy older people (55-77 years old). Two saliva samples were collected during the 
neuropsychological session to obtain cortisol levels and the ApoE genotype. Results 
showed an association between the ApoE genotype and declarative memory, 
specifically learning ability, where ApoE-ε2 group performed better than ApoE-ε4 and 
ApoE-ε3 groups. No differences in cortisol levels were obtained considering the ApoE 
genotype. In addition, higher mean cortisol levels were related to a worse performance 
on declarative memory, for the whole sample, and when considering the three allelic 
variation, for the ApoE-ε4 group. On the contrary, an increase of cortisol levels during 
the neuropsychological session was associated to a better performance on declarative 
memory for the whole sample, and for the ApoE-ε3 group when considering the three 
alleles. Besides, ApoE-ε3 group also showed an association between higher mean 
cortisol levels and a better attention performance. Therefore, our results suggest that 
carrying the ApoE-ε4 allele may be a vulnerability factor in the adverse effects of 
Hypothalamic-Pituitary-Adrenal (HPA axis) dysregulation on cognition during aging, 
while ApoE-ε3 allele could be associated to a more adaptive HPA axis response.  
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1. Introduction 
The increase in life expectancy has aroused interest in the biological 
mechanisms underlying cognition and its decline during aging (Payton et al., 
2005). The Apolipoprotein E (ApoE) polymorphism has been proposed as a mediator 
of this age-related cognitive impairment (Helkala et al., 1996).  
The ApoE gene has three common allelic variations (Bertram, Lill, &Tanzi, 
2010), being the ApoE-ε3 the most common (78%), and the ApoE-ε2 and ApoE-ε4 
alleles are less frequent (8% and 14%, respectively) (Menzel, Kladetzky, &Assmann, 
1983). While the ApoE-ε4 allele presents the main risk factor for late-onset Alzheimer’s 
disease (AD) (Bertram et al., 2010), the ApoE-ε2 allele has been associated with a 
reduced risk (Verghese, Castellano, & Holtzman, 2011). These findings have created 
interest in the role ApoE variants play in the cognitive functioning of healthy people. 
Although two meta-analyses reported that the ApoE-ε4 allele would have adverse 
effects on cognitive function in healthy elderly people (Small, Rosnick, Fratiglioni, & 
Bäckman, 2004; Wisdom, Callahan & Hawkins, 2011), a recent study on mid-adulthood 
supported comparable cognitive performance between ApoE-ε4 carriers and non-
carriers (Lancaster, Tabet & Rusted, 2017). However, Lancaster et al. (2017) concluded 
that the cognitive performance profile of ApoE- ε4 carriers remains elusive. It is worth 
noting that there are some important differences among the empirical studies, such as 
the inclusion of preclinical dementia cases, the cognitive domains assessed, the age 
range of the participants, or the way of grouping the various types of allelic variations. 
Most of the studies group the participants as ApoE-ε4 carriers or non-carriers, without 
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considering the ApoE-ε2 allele independently, which could lead to an overestimation of 
ApoE-ε3 performance and an underestimation of ApoE-ε4 performance.  
In addition to the effects of the ApoE, cognitive function is also affected by the 
Hypothalamic-Pituitary-Adrenal (HPA) axis function through the influence of its end 
product, cortisol. Several studies in healthy older people have reported an association 
between higher cortisol levels and worse memory performance at basal levels (Almela, 
van der Meij, Hidalgo, Villada, & Salvador, 2012; Hidalgo, Almela, Pulopulos, & 
Salvador, 2016) and in response to stress (Almela et al., 2011; Hidalgo, Almela, 
Villada, & Salvador, 2014). Furthermore, increased cortisol levels are a well-established 
feature of AD, although the mechanism responsible for HPA-axis hyperactivity is 
unknown (Gil-Bea et al., 2010; Peskind, Wilkinson, Petrie, Schellenberg, & Raskind, 
2001). This fact, along with the evidence that ApoE-ε4 is a risk factor for developing 
AD (Bertram et al., 2010), suggests that the ApoE gene may affect the association 
between the HPA-axis and cognitive function (Peavy et al., 2007), as animal studies 
have shown (de Kloet, Grootendorst, Karssen & Oitzl, 2002; Grootendorst et al., 2002; 
Grootendorst, Enthoven, Dalm, de Kloet & Oitzl, 2004). Moreover, similar to 
preclinical brain changes related to AD, structural and functional abnormalities of the 
hippocampus have been found in healthy ApoE-ε4 carriers (Lu et al., 2011).  
Nonetheless, studies exploring the associations among the ApoE genotype, 
cognitive function, and the HPA-axis in non-demented older people are scarce and 
report mixed results. Whereas some studies found an association in the ApoE-ε4 allele 
between an HPA-axis alteration and cognitive decline (Gerritsen, Comijs, Deeg, 
Penninx, & Geerlings, 2011; Lee et al., 2008; Peavy et al., 2007; Singh-Manoux et al., 
2014), others failed to find this association (Berteau-Pavy, Park & Raber, 2007; Fiocco, 
Poirier, Joober, Nair & Lupien, 2008; Lara et al., 2013; Li et al., 2006). These different 
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findings could at least partly be explained by some methodological differences. Thus, 
participants with different age ranges (i.e. mean age over 55 (Fiocco et al., 2008), 60 
(Fiocco et al., 2008; Lee et al., 2008; Singh-Manoux et al., 2014), 75 (Gerritsen et a., 
2011; Li et al., 2006; Peavy et al., 2007), and 80 (Berteau-Pavy et al., 2007) years old) 
have been included in the studies. Another difference is the cognitive domain assessed, 
with declarative memory being studied the most (Fiocco et al., 2008; Gerritsen et al., 
2011; Lee et al., 2008; Li et al., 2006; Peavy et al., 2007; Singh-Manoux et al., 2014), 
and only a few studies carried out on object recognition and spatial navigation (Berteau-
Pavy et al. (2007) or attention and executive functioning (Lee et al., 2008; Li et al., 
2006). In addition, most studies employed basal cortisol measures, and only two studies 
measured cortisol levels during the neuropsychological evaluation, with different 
results. Berteau-Pavy et al. (2007) found no association between ApoE alleles, cortisol 
levels, and cognition, whereas Lee et al. (2008) reported that, although higher cortisol 
was associated with lower cognitive performance, the slopes were steeper in the ApoE-
ε4 group. However, these studies included different cognitive tests and inclusion 
criteria. More importantly, none of these studies considered the ApoE-ε2 allele. 
Therefore, more research is needed on the associations among the ApoE genotype, 
cognitive functioning, and cortisol levels during cognitive testing in healthy elderly 
people. 
With all this in mind, we aimed to examine: (i) the differences in several 
cognitive domains (i.e. declarative and working memory, attention, and executive 
function) and cortisol levels during the neuropsychological assessment in different 
ApoE groups and (ii) the relationship between cortisol and cognitive performance, 
taking into account the ApoE groups, in non-stressed, healthy older people from 55 to 
77 years old. To do so, a neuropsychological battery was administered to assess a wide 
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range of cognitive functions. Based on previous literature, we hypothesized that the 
ApoE-ε4 group would show worse cognitive performance, whereas the ApoE-ε2 group 
would show better performance (see Wisdom et al., 2011). We also hypothesized that 
there would be higher cortisol levels in the ApoE-ε4 group, compared to the ApoE-ε2 
and ApoE-ε3 groups (Peskind et el., 2001).  Finally, we expected to find an association 
between higher mean cortisol levels, as well as an increase of cortisol levels during the 
session, and a worse cognitive function, especially on declarative memory, and this 
association would be more pronounced in the ApoE-ε4 group (Gerritsen et al., 2011; 
Lee etal.,2008). 
 
2. Methods 
2.1. Participants   
The final sample was composed of 84 participants of both sexes (40 men and 44 
woman), ranging in age from 55 to 77 years (M= 65.18, SD= 4.631). Most of the 
participants had an educational level beyond high school (79.8%), and their subjective 
socioeconomic status was medium (M= 5.51, SD= 1.086) (subjective SES scale: Adler 
et al., 2000).  
The total sample was categorized in three groups: ApoE-ε2 (n= 9; E2/E2=1 and 
E2/E3=8), ApoE-ε3 (E3/E3=59), and ApoE-ε4 (n=16; E4/E4=2 and E4/E3=14). Due to 
the small number of participants who were homozygous for the E2 and E4 alleles 
(E2/E2=1 and E4/E4=2), both the homozygous and heterozygous participants were 
grouped in the broad category of ApoE-ε2 and ApoE-ε4, respectively. The ApoE group 
frequencies were 10.7 % for ApoE-ε2, 70.2 % for ApoE-ε3, and 19 % for ApoE-ε4. 
There were no significant differences among the ApoE-ε2, ApoE-ε3, and ApoE-ε4 
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groups on sex, age, Body Mass Index (BMI), SES, or educational level (all p> 0.115) 
(Table 1). 
 
 N  
(%) 
Women 
(%) 
Age 
(M) 
 
(SD) 
SES 
(M) 
 
(SD) 
BMI 
(M) 
 
(SD) 
Educational 
level 
Total  
 
84 
(100%) 
52.4% 65.18 4.631 5.51 1.086 27.34 3.248 79.8% 
ApoE-ε2 9 
(10.7%) 
55.6% 62.78 3.383 5.67 .707 27.81 2.693 77.8% 
ApoE-ε3 59 
(70.2%) 
49.2% 65.27 4.634 5.62 1.040 27.35 3.405 81.4% 
ApoE-ε4 16 
(19%) 
62.5% 66.19 4.996 5.00 1.317 27.09 3.050 75% 
  p= .625 p=.203  p=.115  p=.881  p=.627 
Table 1. Descriptive data for the total sample and for each ApoE group (ApoE-ε2, 
ApoE-ε3, and ApoE-ε4). Age, SES (subjective socioeconomic status), and BMI (body 
mass index) are represented as mean values (M) and standard deviation (SD). 
Educational level is represented as the percentage of participants with an educational 
level beyond high school (%). Differences between ApoE status were analyzed with 
ANOVAs (age, SES, and BMI) and chi-square (sex and educational level) analyses. No 
differences in sex, age, SES, BMI, or educational level were found depending on the 
ApoE group (all p ≥ .115). 
 
All the women were postmenopausal and had their last menstrual period more 
than 3 years before the testing time. None of the participants scored less than 28 on the 
MEC (Spanish version of the Mini-Mental Status Examination; Lobo et al., 1999), 
indicating the absence of cognitive impairment. 
Participants were Caucasian, and they were recruited from a study program at 
the University of Valencia for people over 55 years of age. Two hundred and twenty 
volunteers were interviewed by telephone in order to check whether they met the study 
prerequisites. Exclusion criteria were: smoking more than 10 cigarettes a day, alcohol or 
other drug abuse, visual or hearing problems, diabetes, neurological or psychiatric 
disease, using any medication directly related to emotional or cognitive functioning or 
able to influence hormonal levels such as glucocorticoids, psychotropic substances, or 
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sleep medications, having been under general anesthesia once or more than once in the 
past year, and the presence of a stressful life event during the past year.  
One hundred twenty-eight individuals participated in the study, of whom 37 were 
eliminated because they did not meet the inclusion or exclusion criteria: 20 participants 
for using medication related to emotional or cognitive functioning or able to influence 
hormonal levels, such as glucocorticoids, psychotropic substances, or sleep 
medications; 7 participants for having diabetes; 4 participants due to severe and 
uncorrected visual or hearing problems; 4 participants for having a stressful life event 
during the past year; 1 for alcohol abuse; and 1 participant for having been under 
general anesthesia in the past year. Of the remaining 91 participants, the ApoE 
polymorphism of three participants could not be genotyped, and one participant was 
excluded for being ApoE-ε2/ε4. Finally, after dividing the sample according to the 
ApoE genotype (ApoE-ε2, ApoE-ε3 and ApoE-ε4), three participants in the ApoE-ε3 
group were excluded from the analyses, two participants because their cortisol 
concentrations differed by more than 2.5 SD from the mean, and one participant 
because his age differed by more than 2.5 SD from the mean. 
 
2.2. Procedure 
Participants who met the criteria were asked to attend one session that took place 
from 10:00 to 12:00 hours in a laboratory at the Faculty of Psychology. Before the 
session, participants were asked to maintain their general habits, sleep as long as usual, 
refrain from heavy physical activity the day before the session, and not consume alcohol 
from the night before the first session. They were also instructed to drink only water, 
and not eat, smoke, take any stimulants (such as coffee, cola, caffeine, tea or chocolate), 
or brush their teeth at least 1 hour prior to the session. All participants provided written 
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informed consent to participate in the study, which was conducted in accordance with 
the Declaration of Helsinki. The protocol was approved by the Research Ethics 
Committee of the University of Valencia. In this session, a neuropsychological battery 
was administered. Additionally, participants were asked to provide two saliva samples, 
from which the ApoE genotype and cortisol levels were extracted. The first saliva 
sample was collected at the beginning of the neuropsychological evaluation (pre-test 
cortisol), which took place 15 minutes after the participant’s arrival. The second saliva 
sample was collected at the end of the neuropsychological evaluation (post-test 
cortisol), which took place 1 hour and 25 minutes after the beginning of the 
neuropsychological evaluation. 
 
2.3. Neuropsychological tests 
2.3.1. Declarative memory 
2.3.1.1. Rey Auditory Verbal Learning Test (RAVLT). The Spanish version of 
the RAVLT (Miranda & Valencia, 1997) was used.  This task consists of a target list 
(List A) of 15 neutral words repeated five times by the experimenter (trials I–V: Total 
Learning) that participants had to learn. Then, an interference list (List B) was presented 
only once, and participants had to repeat it. Participants were asked to recall the target 
list again immediately after the interference list (trial VI), and again after a delay of 20 
min (trial VII). Three outcomes were used in subsequent analyses: (i) RAVLT Total 
Learning: total number of words recalled on the first five trials (trial I to V); (ii) 
RAVLT Immediate Recall: percentage of total number of words recalled after the 
interference trial compared to the number of words recalled on trial V (trial VI/trial V x 
100); and (iii) RAVLT Delayed Recall: percentage of total number of words recalled 
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after the 20-min delay compared to the number of words recalled on the immediate 
recall trial (trial VII/trial VI x 100). 
2.3.1.2. Rivermead Stories Subtest. The Story recall subtest from the Spanish 
version of the Rivermead Behavioral Memory Test (Wilson, Cockburn, &Baddeley, 
1985) was used. The experimenter read aloud two short stories, and participants had to 
recall as many memory units or ‘‘ideas’’ as possible immediately after their oral 
presentation and after a 20-min delay. Participants’ answers were audio recorded and 
corrected by an expert, and the sum of the correctly recalled ‘‘ideas’’ from the two 
stories was calculated. From this test, two outcomes were used for the subsequent 
analysis: (i) Rivermead Immediate recall: total “ideas” recalled from the two stories 
immediately after the oral presentation and (ii) Rivermead Delayed recall: total “ideas” 
recalled from the two stories after 20 min, compared to the number of “ideas” recalled 
from the two stories immediately after the oral presentation (Delayed recall/ Immediate 
recall x100).  
2.3.2. Working memory (WM) 
2.3.2.1. Digit Span (DS). The Spanish version of the Wechsler Memory Scale III 
was administrated (Wechsler, 1997). The experimenter read aloud a series of numbers 
(from 0 to 9) of increasing length (from 2 to 9 digits) at a rate of one digit per second. 
The participant had to repeat the numbers, first in the same order (DS-Forward) and 
then in reverse order (DS-Backward). Each set length was tested twice. The test was 
finalized when the participant failed two consecutive trials of the same length. For each 
correctly repeated digit set, one point was given. Two outcomes were obtained: (i) DS-
Forward: total number of correctly recalled attempts in the same order and (ii) DS-
Backward: total number of correctly recalled attempts in the reverse order. DS-Forward 
was used as a measure of the attention and memory span component of WM, whereas 
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DS-Backward was used as a measure of the executive component of WM (Conklin, 
Curtis, Katsanis, Iacono, 2000). 
2.3.2.2. Letter-number sequencing (LNS). The Spanish version of the Wechsler 
Memory Scale III was administrated (Wechsler, 1997).  The experimenter read aloud a 
series of mixed numbers (from 0 to 9) and letters (from A to Z) of increasing length 
(from 2 to 8 items). The participant had to repeat the series, ordering the numbers in 
ascending order and the letters in alphabetical order. Each set length was tested three 
times. The test was finalized when the participant failed three consecutive trials of the 
same length. One point was given for each correctly recalled attempt. One outcome was 
obtained: LNS (total number of correctly recalled attempts). 
2.3.3. Executive Function 
2.3.3.1. Trail-Making Test (TMT). The TMT (Reitan, 1992) consists of two 
trials, TMT-A and TMT-B, each composed of 25 circles distributed on a white sheet of 
paper. In TMT-A, the circles were numbered from 1 to 25, and the participant was 
asked to trace a line connecting the circles in numerical sequence as quickly as possible. 
TMT-B included numbers from 1 to 13 and letters from A to L, and the participant was 
instructed to alternate between numbers and letters in ascending sequence. The score 
obtained was the number of seconds required to finish each trial. Errors were pointed 
out instantly by the examiner and contributed to the score, due to the additional time 
needed for corrections. Two outcomes were obtained: (i) TMT-A: total number of 
seconds required to finish the TMT-A, and (ii) TMT-B: total number of seconds 
required to finish the TMT-B. The TMT-A was used to assess attention and general 
psychomotor speed, whereas the TMT-B was used to evaluate attention-switching 
performance. 
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2.3.3.2. Stroop Color-Word Interference test. Golden’s version of the Stroop 
Color-Word Interference Test (Golden, 1978) was administered. The test is composed 
of three trials. In each trial, participants had to name as many words as possible in 45 
seconds. In the first trial, participants had to read the written word (W), which was red, 
blue, or green. In the second trial, participants had to name the printed color (C), red, 
blue, or green, of the XXX letters. In the third trial, participants had to name the color of 
the printed word (red, blue, or green), which was different from the written word (red, 
blue, or green) (WC), for example, the word green printed in red color. Afterwards, the 
WC’ was calculated (WC’ = (W x C) / (W + C)). Finally, the Stroop Interference 
outcome was obtained (Stroop Interference = WC – WC’), which is a measure of the 
ability to inhibit automatic responses.  
 
2.4. Biochemical analyses 
Participants provided two saliva samples by using salivettes (Sarstedt, 
Nümbrecht, Germany), the first one at the beginning of the neuropsychological 
assessment, and the second one at the end of the session. Participants were instructed to 
keep the cotton swab in their mouths for exactly 2 min, not chew the cotton, and move 
the swab around in a circular pattern to collect saliva from all salivary glands. The 
samples were centrifuged at 3000 rpm for 5 min, resulting in a clear supernatant of low 
viscosity that was stored at -80oC until the analyses of cortisol and ApoE genotype 
determination were performed. 
2.4.1. Salivary Cortisol 
The activity of the HPA-axis was measured by analyzing the salivary cortisol 
levels. Each sample was measured in duplicate, and each participant’s samples were 
analyzed in the same trial. The salivary cortisol samples were analyzed by a competitive 
  
 13 
solid phase radioimmunoassay (tube coated), using the commercial kit Spectria Cortisol 
RIA (cat. Nu 06119) from Orion Diagnostica (Espoo, Finland). Assay sensitivity was 
0.8 nmol/L, and the within- and inter-assay variation coefficients were all below 8%. 
Salivary cortisol levels were determined in the Central Research Unit of the Faculty of 
Medicine, University of Valencia (Spain). 
2.4.2. ApoE genotype determination 
To determine the ApoE genotype, the genomic deoxyribonucleic acid (DNA) was 
isolated from the saliva by using a standard commercial extraction method (KIT 
REALPURE “SSS”). The genotype of each ApoEpolymorphism was amplified by the 
polymerase chain reaction (PCR) using two primers: Forward 
(ACAGAATTCGCCCCGGCCTGGTACAC) and Reverse 
(TAAGCTTGGCACGCCTGTCCAAGGA). Subsequently, DNA was digested with the 
Hhal restriction enzyme. Next, DNA electrophoresis in 2% agarose gel was performed. 
Finally, after ethidium bromide staining, the DNA-banding patterns (ApoE-ε2, ApoE-ε3 
and ApoE-ε4) were visualized under the ultraviolet lamp and recorded for further 
analysis. The ApoE genotype was determined at the Department of Genetics of the 
University of Valencia (Spain). 
 
2.5. Statistical Analysis 
Participants’ characteristics were described using percentages or means 
(standard deviation, SD) when appropriate, according to the ApoE groups (ApoE-ε2, 
ApoE-ε3, and ApoE-ε4).  
To investigate whether there were differences between the ApoE groups in age, 
BMI, and SES, one-way analyses of variance (ANOVAs) were performed. Pearson’s 
Chi-square test was used to assess differences in sex and education level.  
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Before statistical analyses were performed, cortisol data were checked for 
normal distribution and homogeneity of variance using Shapiro-Wilks and Levene’s 
test. These analyses revealed significant deviations in cortisol values; therefore, cortisol 
data were logarithm 10 (Log10) transformed. The mean cortisol index was obtained 
averaging pre-test and post-test cortisol levels and the delta cortisol index by 
subtracting post-test cortisol minus pre-test cortisol levels.  
To investigate whether there were differences in cognitive performance and 
cortisol levels among the ApoE groups, we performed one-way ANOVAs. As 
dependent variables, we used the following outcomes from the (i) RAVLT: RAVLT 
Total Learning, RAVLT Immediate recall, and RAVLT Delayed recall, (ii) Rivermead 
stories: Rivermead Immediate recall and Rivermead Delayed recall, (iii) DS: DS-
Forward and DS-Backward, (iv) LNS, (v) TMT: TMT-A and TMT-B, (vi) Stroop 
interference, and (vii) mean cortisol. Post-hoc comparisons were performed using 
Bonferroni adjustments for the p values.  
In addition, to analyze the change in cortisol levels during the 
neuropsychological assessment an ANOVA for repeated measures analysis was 
performed including Time (pre-test and post-test cortisol) as a within-subject factor and 
ApoE group as an between-subject factor. These analyses were performed unadjusted 
and adjusted for the covariates age, sex, SES and IMC.  
Next, to investigate whether an association exists between cortisol levels and the 
different cognitive domain outcomes, linear regressions were performed, unadjusted and 
adjusted for covariates, as previous studies showed that cortisol levels and/or cognition 
could be affected by sex (Almela et al., 2011), age (Kudielka, Buske-Kirschbaum, 
Hellhammer, & Kirschbaum, 2004; Van Hooren et al., 2007), SES (Cohen, Doyle, & 
Baum, 2006), level of education (Sattler, Toro, Schönknecht & Schröder, 2012), and 
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BMI (Champaneri et al., 2013; Cournot et al., 2006). Thus, separate analyses were 
performed for each cognitive domain as dependent variable. For unadjusted analyses, 
we included cortisol indexes (mean or delta) in step one. For adjusted analyses, we 
included sex, age, BMI, SES, and educational level as covariates in step one, following 
stepwise analysis. In step 2, cortisol indexes (mean or delta) were included. Finally, in 
order to investigate whether the relationships between the cortisol levels and the 
different cognitive domain outcomes were different depending on the ApoE group, 
these analyses were repeated with the sample divided into ApoE groups. 
All p values were two-tailed, and the level of significance was taken as p<0.05. 
To perform these statistical analyses, version 22.0 of SPSS was used.  
 
3. Results 
3.1. ApoE group differences in cognitive function  
One-way ANOVAs revealed significant effects of the ApoE groups on Total 
Learning from the RAVLT test (F (2, 81) = 4.191, p = .019). Post hoc analysis revealed 
significant differences between the ApoE-ε2 and ApoE-ε4 groups (p = .015), showing 
that the ApoE-ε2 group obtained higher scores than the ApoE-ε4 group. A marginal 
difference was also observed, where the ApoE-ε2 group obtained higher scores than the 
ApoE-ε3 group (p = .065) (Figure 1). None of the other cognitive domain outcomes 
showed significant differences among the ApoE groups. For the rest of the tests that 
evaluated declarative memory, no significant differences were found between the ApoE 
groups on immediate (F (2, 81) =1.298, p =. 279) and delayed recall (F (2, 81) =2.552, p 
= .084) from the RAVLT test, or immediate (F (2, 80) = .034, p = .967) and delayed 
recall (F (2,80) = .791, p =.457) from the Rivermead test.  Likewise, no significant 
differences were found between the ApoE groups on the tests that evaluated working 
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memory, such as the DS-Forward (F (2, 81) = 1.113, p= .333), DS-Backward (F (2, 80) 
= .228, p = .796), and LNS (F (2, 81) = .694, p = .503). Finally, no significant 
differences were found between the ApoE groups on the tests that assessed executive 
function attention, such as TMT-A (F (2, 80) =1.212, p = .303), TMT-B (F (2, 80) = 
.329, p = .720), and Stroop interference (F (2, 78) = .360, p = .699).  
 
 
Figure 1.  Mean performance on RAVLT Total Learning according to APOE group. 
One-way ANOVAs showed significant differences in declarative memory performance 
between ApoE groups (p=.019). Post hoc analysis showed better performance in the 
ApoE-ε2 group compared to ApoE-ε4 (*p=. 015). Although without reaching 
significance, a trend was also observed where the ApoE-ε2 group performed better than 
the ApoE-ε3 group (p=.065). 
 
3.2. ApoE group differences in cortisol levels 
The results showed no significant differences among the ApoE groups in mean 
cortisol levels (F (2, 80) = 1.351, p= .265) (Table 2). 
 Total  ApoE-ε2 ApoE-ε3 ApoE-ε4 
 M SEM M SEM M SEM M SEM 
Mean cortisol 5.747 .286 6.437 .651 5.733 .317 5.406 .887 
Table 2. Cortisol data (nmol/L) for the total sample and for each ApoE group (ApoE-
ε2, ApoE-ε3, and ApoE-ε4) are represented as mean values (M) and standard error of 
mean (SEM). 
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The ANOVA for repeated measures showed an effect of Time (F (1, 80) = 
5.483, p =.022), where cortisol levels decreased along the session. On the contrary, no 
interaction Time*ApoE group (F (2, 80) = .579, p=.563) was observed. These results 
were similar after controlling for age, sex, SES and BMI (Time: F (1, 74) = 4.396, p 
=.039; Time*ApoE group: F (2, 74) = 1.607, p =.207). 
 
3.3. Relationship between cortisol levels and cognitive function 
Unadjusted regression analyses showed, for the complete sample, a negative 
association between mean cortisol levels and the delayed recall on the RAVLT test (p = 
.009), and marginally with immediate recall on the Rivermead story test (p = .077). 
Besides, a negative association was observed between mean cortisol levels and time 
performing the TMT A test (p = .037). In addition, delta cortisol was positively 
associated with time performing the TMT B (p = .038) and, marginally, with delayed 
recall on the RAVLT test (p = .055).   
After repeating these analyses considering the ApoE groups, only the ApoE-ε4 
group showed a negative association between mean cortisol levels and delayed recall on 
the RAVLT (p = .021) and immediate recall on the Rivermead story test (p = .012). On 
the other hand, only the ApoE-ε3 group showed a negative association between mean 
cortisol levels and time performing the TMT A (p = .019). Also, in this group a positive 
association between delta cortisol and delayed recall on the RAVLT (p = .023) and time 
performing the TMT B (p = .039), as well as a negative association between delta 
cortisol and DS-Forward performance (p = .049) were found. 
Adjusted regression analyses showed that, for the complete sample, higher mean 
cortisol levels were related to worse performance on delayed recall on the RAVLT test 
(p = .009) and immediate recall on the Rivermead story test (p = .026). In turn, a trend 
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was observed where higher cortisol levels were associated with lower times performing 
the TMT A (p = .060) and, therefore, better performance. Regarding the delta index, an 
increase of cortisol levels during the session was related to a better performance on 
delayed recall on the RAVLT test (p = .028) and, marginally, to learning ability on the 
RAVLT test (p = .052).  
After repeating these analyses considering the ApoE groups, only the ApoE-ε4 
group showed a negative association between mean cortisol levels and performance on 
delayed recall on the RAVLT test (p = .015) and immediate recall on the Rivermead 
story test (p = .008). In addition, for the ApoE-ε3 allele it was observed a negative 
association between mean cortisol levels and time performing the TMT A (p = .024). 
Besides, only the ApoE-ε3 group showed a positive association between delta cortisol 
and performance on delayed recall on the RAVLT test (p = .007), as well as a trend with 
performance on learning ability on the RAVLT test (p = .093). None of the other 
associations were significant (all p> .110) (Table 3 and 4).  
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  RAVLT 
Total  
Learning 
RAVLT 
 Immediate 
Recall 
RAVLT 
Delayed 
Recall 
Rivermead 
Immediate 
Recall 
Rivermead 
Delayed 
Recall 
DS- 
Forward 
DS- 
Backward 
LNS TMT-A TMT-B Stroop 
Interfe- 
rence 
Unadjusted analyses 
Total AdjR2 .004 -.007 .069 .026 -.012 -.012 -.012 -.012 .041 -.011 -.012 
 Beta -.126 .069 -.284 -.196 -.006 .020 .006 -.010 -.230 .033 .024 
 p .256 .533 .009 .077 .956 .858 .958 .928 .037 .768 .830 
ApoE-ε2 AdjR2 -.069 -.142 -.086 .164 -.125 -.081 -.053 .092 -.142 -.141 -.141 
 Beta -.254 -.020 .223 -.518 -.126 .233 .281 -.454 -.024 -.036 .044 
 p .510 .960 .564 .153 .747 .546 .464 .220 .951 .926 .910 
ApoE-ε3 AdjR2 .028 -.017 .017 -.017 .005 .009 -.006 -.017 .079 -.017 -.014 
 Beta -.212 -.019 -.185 -.027 -.150 .163 .111 .026 -.309 -.028 -.070 
 p .110 .885 .165 .841 .265 .222 .409 .847 .019 .837 .611 
ApoE-ε4 AdjR2 -.056 .034 .277 .325 .024 .073 .111 -.065 -.071 .068 .083 
 Beta -.119 .314 -.570 -.609 .298 -.368 -.413 -.075 -.003 .361 .379 
 p .661 .237 .021 .012 .263 .161 .112 .783 .990 .170 .147 
Adjusted analyses for covariates 
Total AdjR2 .003 -.005 .072 .227 -.013 .364 .163 .285 .085 .193 -.012 
 Beta -.125 .085 -.289 -.224 -.016 -.015 -.022 -.030 -.206 .062 .033 
 p .267 .452 .009 .026 .888 .867 .828 .751 .060 .544 .771 
ApoE-ε2 AdjR2 -.160 -.153 -.121 -.047 -.071 -.111 -.127 .551 -.088 -.167 -.124 
 Beta -.073 .109 .197 -.320 -.287 .218 .185 -.394 .260 -.003 .192 
 p .863 .798 .639 .440 .491 .605 .662 .189 .535 .995 .649 
ApoE-ε3 AdjR2 .032 -.018 .019 .102 .009 .390 .180 .376 .074 .056 -.015 
 Beta -.221 -.004 -.190 -.086 -.163 .091 .124 -.038 -.302 .015 -.063 
 p .098 .974 .156 .505 .229 .394 .314 .723 .024 .909 .653 
ApoE-ε4 AdjR2 .161 .034 .548 .605 .261 .640 .280 -.065 .190 .068 .083 
 Beta -.032 .314 -.491 -.518 .221 .010 -.250 -.075 -.096 .361 .379 
 p .895 .237 .015 .008 .343 .956 .303 .783 .690 .170 .147 
Table 3. Regression analyses with mean cortisol as predictor and cognitive outcomes as dependent variables, unadjusted and adjusted for 
covariates. Values in bold represent significant or marginal p values.  
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  RAVLT 
Total 
Learning 
RAVLT 
Immediate 
Recall 
RAVLT 
Delayed 
Recall 
Rivermead 
Immediate 
Recall 
Rivermead 
Delayed 
Recall 
DS- 
Forward 
DS- 
Backward 
LNS TMT-A TMT-B Stroop 
Interfe- 
rence 
Unadjusted analyses 
Total AdjR2 .013 -.009 .033 -.008 -.002 .014 -.010 .014 -.011 .041 -.013 
 Beta .158 .058 .211 -.065 -.100 -.162 .049 -.162 .038 .230 .014 
 p .154 .604 .055 .564 .371 .143 .661 .143 .736 .038 .904 
ApoE-ε2 AdjR2 -.135 -.085 -.012 -.098 -.045 -.143 -.143 -.003 -.116 -.083 -.142 
 Beta .084 -.225 .339 -.198 -.293 -.001 .012 -.305 .154 .228 .022 
 p .830 .560 .372 .609 .444 .997 .976 .356 .693 .555 .955 
ApoE-ε3 AdjR2 .011 -.007 .073 -.017 -.016 .051 -.018 .024 -.014 .059 -.019 
 Beta .168 .105 .299 -.030 -.042 -.260 .024 -.204 .064 .275 -.002 
 p .207 .433 .023 .825 .757 .049 .860 .125 .636 .039 .991 
ApoE-ε4 AdjR2 -.071 -.066 -.057 -.064 -.018 -.071 -.054 -.068 -.071 -.059 -.070 
 Beta -.006 .071 -.116 -.081 -.224 -.023 .126 .057 -.020 .109 .039 
 p .983 .794 .669 .765 .404 .932 .642 .835 .941 .689 .886 
Adjusted analyses for covariates 
Total AdjR2 .035 -.013 .048 .182 -.007 .365 .190 .284 .042 .191 -.013 
 Beta .216 .008 .245 .083 -.074 .035 .165 .009 -.017 .045 -.004 
 p .052 .945 .028 .425 .514 .700 .112 .927 .876 .666 .973 
ApoE-ε2 AdjR2 -.094 -.136 -.044 -.167 .026 -.166 -.160 .418 -.009 -.085 -.152 
 Beta .249 -.162 .324 .009 -.407 -.031 -.077 -.231 .367 .265 .112 
 p .551 .702 .434 .983 .318 .943 .885 .460 .371 .527 .792 
ApoE-ε3 AdjR2 .033 -.017 .107 .103 -.018 .383 .197 .375 -.018 .075 -.018 
 Beta .224 .034 .351 .092 .016 -.035 .182 -.008 .015 .137 -.041 
 p .093 .799 .007 .480 .910 .750 .146 .938 .915 .300 .769 
ApoE-ε4 AdjR2 .161 -.066 .304 .306 .248 .669 .247 -.068 .183 -.059 -.070 
 Beta .027 .071 -.156 -.041 -.189 .202 -.186 .057 -.054 .109 .039 
 p .909 .794 .483 .851 .415 .349 .480 .835 .820 .689 .886 
Table 4. Regression analyses with delta cortisol as predictor and cognitive outcomes as dependent variables, unadjusted and adjusted for 
covariates. Values in bold represent significant or marginal p values.  
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Finally, to investigate whether the significant relationships between mean or 
delta cortisol and the cognitive outcomes were statistically different for the three 
groups, we conducted regression models using PROCESS (v2.13.6). To do this, 
separately regression models with each cognitive measure tested as the dependent 
variable (i.e., RAVLT delayed recall, Rivermead Immediate recall or TMT A), the 
cortisol indexes (mean or delta) as the independent variables, the ApoE group (ApoE-
ε2, ApoE-ε3, and ApoE-ε4) as the moderator variable, and age, sex, BMI, SES and 
educational level as covariates were performed.  
In order to decompose the significant interactions between ApoE and the 
regression estimates, we ran a second model with the two ApoE dummy varibles as 
moderator variables (ApoE-ε2 vs ε3 and ApoE-ε2 vs ε4; ApoE-ε3 vs ε2 and ApoE-ε3 vs 
ε4; ApoE-ε4 vs ε2 and ApoE-ε4 vs ε3, depending on the allele where the significant 
relationship had been observed), and age, sex, BMI, SES, and educational level as 
covariates. The regression model for RAVLT delayed recall revealed a main effect of 
mean cortisol (p=.013), a main effect of ApoE (p=.012), and a significant mean 
cortisol*ApoE interaction (p=.013). By decomposing this interaction for RAVLT 
delayed recall, we did not obtain a significant mean cortisol*ApoE-ε4 vs ε2 (p=.156) 
interaction, or a mean cortisol*ApoE-ε4 vs ε3 (p=.085) interaction, although a trend was 
observed in the latter. By contrast, we did not find a significant mean cortisol*ApoE 
interaction for Rivermead Immediate recall (p= .464) or the TMT A (p=.640), nor a 
significant delta cortisol*ApoE interaction for RAVLT delayed recall (p=.360) (Table 
5). It is important to note that, given our sample size and the different proportions of 
participants in each ApoE group, there may not be enough statistical power to detect 
some interactions. Therefore, these exploratory results should be interpreted with 
caution. 
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Table 5. Regression analyses with cortisol (mean or delta), ApoE, and cortisol (mean or delta) *ApoE as predictors, and cognitive outcomes 
(RAVLT delayed recall, Rivermead immediate recall and TMT A) as dependent variables, adjusted for covariates. Decomposition of significant 
mean cortisol*ApoE interactions were performed with regression analyses with mean cortisol, ApoE-ε4 vs ε2 and ApoE-ε4 vs ε3, and mean 
cortisol*ApoE-ε4 vs ε2 and mean cortisol*ApoE-ε4 vs ε3 as predictors, and RAVLT delayed recall, as dependent variable, adjusted for 
covariates. Values in bold represent significant or marginal p values. 
 RAVLT delayed recall Rivermead immediate recall TMT A 
 Beta p 95% CI Beta p 95% CI Beta p 95% CI 
Mean cortisol 110.126 .043 3.481, 216.771 7.680 .688 -30.330, 45.691 -33.542 .421 -116.301, 49.216 
ApoE 31.608 .012 7.051, 56.165 3.949 .371 -4.800, 12.699 -3.172 .740 -22.230, 15.885 
Mean cortisol*ApoE  -41.062 .013 -73.459, -8.665 -4.252 .464 -15.793, 7.288 5.916 .640 -19.225, 31.057 
          
Mean cortisol -49.719 .004 -83.242, -16.196       
ApoE-ε4 vs ε2 -52.174 .188 -130.610, 26.262       
ApoE-ε4 vs ε3 -30.050 .037 -58.328, -1.773       
Mean cortisol*ApoE-ε4 vs ε2 69.679 .156 -27.400, 166.758       
Mean cortisol*ApoE-ε4 vs ε3 34.897 .085 -4.986, 74.781       
          
Delta cortisol 59.664 .183 -28.856,   148.185       
ApoE 3.425 .288 -2.953,  9.804       
Delta cortisol*ApoE  -13,667 .360 -43.248,  15.914       
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4. Discussion 
We aimed to examine the differences between the ApoE groups in cognitive 
performance and cortisol levels during the neuropsychological assessment in healthy 
older people. Our second aim was to analyze the association between cortisol levels and 
cognitive performance, taking into account the three ApoE groups. To do so, we 
explored these possible relationships, first in the complete sample and then for each 
ApoE group.  
Regarding our first aim, our results showed significant differences among the 
ApoE groups only on declarative memory, where, consistent with previous results, 
ApoE-ε2 allele carriers performed better than the other allele groups (Wisdom et al., 
2011); specifically, Helkala et al. (1995; 1996) also observed better learning ability in 
the ApoE-ε2 group, but in a sample of older elderly people (mean age 74 years old). 
However, contrary to what was reported by Wisdom et al. (2011) in their meta-analysis, 
we found no differences in declarative memory between the ApoE-ε3 and ApoE-ε4 
groups. It is worth noting that, more recently, Lancaster et al. (2017) did not report 
differences in cognitive function between ApoE-ε4 carriers and non-carriers in mid-
adulthood (mean age between 35 and 60 years). In addition, in our study, all participants 
underwent very restrictive criteria (28 on the MEC), indicating no cognitive 
impairment, whereas it has been reported that cognitive deficits related to the ApoE-ε4 
allele could be due to the inclusion of preclinical cases of AD (Batterham, Bunce, 
Cherbuin, & Christensen, 2012).    
No differences were found among the ApoE groups in mean cortisol levels, 
coinciding with a lack of association between serum or salivary cortisol levels and the 
ApoE genotype in AD and healthy controls (Fiocco et al., 2008; Lara et al., 2013; Li et 
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al., 2006).  However, an association between higher CFS cortisol levels and the ApoE-
ε4 allele was also found in AD patients (Gil-Bea et al., 2010; Peskind et al., 2001) and 
healthy elderly people (Peskind et al., 2001). As cortisol secretion follows a diurnal 
rhythm, with a peak after awakening and a steady decline throughout the day (Edwards, 
Evans, Hucklebridge, & Clow, 2001), in our study cortisol levels decreased during the 
session. However, we did not observe an effect of ApoE group, suggesting that no 
differences between groups occur in cortisol secretion. However, it is important to note 
that this result may also be due to the relatively small sample size of the groups, and 
more research is needed. 
Regarding our second aim, for the complete sample, higher mean cortisol levels 
were associated with worse declarative memory performance, which is consistent with 
previous studies (Lee et al., 2007; Li et al., 2006; MacLullichet al., 2005; Seeman, 
McEwen, Singer, Albert, & Rowe, 1997; Vedhara, Hyde, Gilchrist, Tytherleigh, & 
Plummer, 2000; Wright, Kunz-Ebrecht, Iliffe, Foese, & Steptoe, 2005). In addition, a 
trend was observed where higher mean cortisol levels were associated with less time 
performing the TMT-A and, therefore, better attention. Glucocorticoid receptors are 
widely distributed in the hippocampus and prefrontal cortex, which are involved in 
declarative memory and attention and executive function, respectively (Lupien, Maheu, 
Tu, Fiocco, & Schramek, 2007). An inverted-U pattern has been observed in the 
association between cortisol and cognition, suggesting that very low or high 
glucocorticoids levels would worsen cognitive performance, while medium levels 
would facilitate it (de Kloet, Oitzl, & Joëls, 1999; Lupien et al., 2007). Therefore, our 
results suggest that the point at which cortisol levels begin to impair cognitive 
performance would be different for declarative memory and attention, justifying the fact 
that higher cortisol levels worsened declarative memory but improved attention. On the 
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other hand, although higher mean cortisol levels worsened declarative memory 
performance, it was also observed that a progressive increase along the session 
improved it. Hence, these results would also support the inverted-U pattern, and 
highlights the complex dynamics that exist in the relationship between cortisol levels 
and cognitive function. 
When we analyze the groups categorized by the ApoE allele, the association 
between higher mean cortisol levels and worse declarative memory performance, both 
immediate and delayed recall, was only observed in the ApoE-ε4 group. In addition, we 
found a significant interaction between ApoE and mean cortisol levels for delayed 
recall, but not for immediate recall. Although few studies have explored cognitive 
function, the HPA-axis, and ApoE polymorphism together, previous results showed an 
association between the ApoE-ε4 allele, a faster decline in verbal fluency, and a flatter 
diurnal slope, that is, higher evening cortisol and lower morning cortisol (Gerritsen et 
al., 2011; Singh-Manoux et al., 2014). As mentioned above, two studies explored these 
associations by measuring cortisol levels during the cognitive assessment (Berteau-Pavy 
et al., 2007; Lee et al., 2008). Berteau-Pavy et al. (2007) found that in people from 62 to 
92 years old, the ApoE-ε4 allele was associated with worse performance on the object 
recognition and spatial navigation test, but they did not find a relationship with cortisol 
levels. By contrast, Lee et al. (2008) observed that, whereas higher cortisol was 
associated with lower cognitive performance, the slopes were steeper in the ApoE-ε4 
group. This study was carried out in participants with a similar age range (50-70 years), 
and it assessed similar cognitive domains to those assessed in our study. However, in 
Lee et al. (2008), subjects were not clinically assessed for dementia, and they were not 
excluded due to drug or medication use, which could have altered cognition or diseases 
such as diabetes (19.3% of the sample) despite it has been observed a dysregulation in 
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the HPA-axis function in responses to stress (Steptoe et al., 2014).  In addition, these 
authors grouped the participants only as ApoE-ε4 allele carriers and non- carriers. Thus, 
in our study, we consider the three allelic variations (ApoE-ε2, ApoE-ε3 and ApoE-ε4), 
and cortisol was obtained while a wide range of cognitive functions were assessed. The 
findings support the idea that, in healthy non-demented older people from 55 to 77 years 
old, ApoE-ε4 carriers might be more vulnerable to potential detrimental effects of HPA-
axis dysfunction on verbal memory performance.  
On the contrary, only the ApoE-ε3 group showed an association between an 
increase of cortisol levels during the neuropsychological assessment and a better 
declarative memory performance, suggesting a more adaptive response to a cognitive 
challenge of the HPA axis in this group. What is more, the association between higher 
mean cortisol levels and better TMT A performance, was only observed in ApoE-ε3 
group. Therefore, our findings would also support lower vulnerability in ApoE-ε3 to the 
detrimental effects of cortisol on attention and eye-hand coordination. Recently, 
Piskunowicz et al. (2017) reported that ApoE-ε3 allele carriers performed better on 
TMT B than ApoE-ε2 and ApoE-ε4 allele carriers. Therefore, our results show that the 
ApoE genotype modulates attention and eye-hand coordination, and the ApoE-ε3 allele 
would confer an advantage compared to the other alleles. Finally, it is worth noting that 
we found no association between cortisol levels and cognition for the ApoE-ε2 allele, 
despite it has been related to an increased risk of developing post-traumatic stress 
disorder (Kim et al., 2013), susceptibility to stress-induced impairments in memory 
(Freeman, Roca, Guggenheim, Kimbrell, & Griffin, 2005) and HPA axis dysregulation 
(Johnson et al., 2015).  
Some limitations should be considered. First, it is important to note the 
correlational nature of the results, and so we cannot claim causal relationships. In 
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addition, due to the unequal distribution of the three ApoE alleles and the low frequency 
of the ApoE-ε2 and ApoE-ε4 alleles in the population, in our sample the number of 
participants in each ApoE group differed, and the sample size for the ApoE-ε2 and the 
ApoE-ε4 groups was small. Therefore, it is possible that, due to the small sample sizes, 
some of the hypothesized results were not observed. Thus, a larger sample size would 
be necessary to increase the statistical power. Nevertheless, it is important to highlight 
the effort that has been made in this study to separate and compare the three allelic 
variations and study their relationship with a wide range of cognitive domains and the 
HPA axis. In addition, the strict exclusion criteria make it possible to obtain a healthy 
older sample and control the effect of confounding variables. Moreover, due to the 
sample size, sex differences were not taken into account, although several studies with 
healthy elderly people have shown that women outperform men on verbal memory 
(Zhang, Zhou, Wang, Zhang & Study, 2017; Munro et al., 2012). Furthermore, there is 
evidence that women are at higher risk of AD than men (Farrer et al, 1997), and so it 
seems necessary to study sex differences in the influence of the ApoE gene on cognitive 
function. Thus, future studies with larger samples are needed to shed light on this issue.  
 
In summary, our results show that, in healthy older people, the ApoE-ε2 allele 
may have a protective effect on declarative memory, specifically learning ability and no 
association between cortisol levels and cognition was observed for this allelic group.   
In addition, we did not find differences in cortisol levels between the ApoE groups. 
Additionally, although the ApoE-ε4 allele did not show a negative effect on cognitive 
function compared to ApoE-ε3, high cortisol levels would be especially detrimental to 
declarative memory in this group, compared to the ApoE-ε2 and ApoE-ε3 groups. Thus, 
the ApoE-ε4 allele could add greater vulnerability to the adverse effects of HPA axis 
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dysregulation on declarative memory during aging.  On the other hand, the ApoE-ε3 
allele could be related to a more adaptive stress response, where higher cortisol levels 
would improve attention and declarative memory. 
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Highlights 
1. No differences on cognition in ApoE-ε3 and ε4 allele carriers in healthy elderly  
2. Protective effect of ε2 allele in learning ability  
3. Vulnerability effect of ε4 allele on HPA-axis dysregulation and cognitive 
decline 
4. Adaptive HPA-axis response of ε3 allele to a cognitive challenge  
5. Beneficial role of ε3 allele on the effects of cortisol on attention and memory 
 
 
 
 
 
 
 
 
